LATEST ARTICLES
Canada
Smart & Biggar
On November 10, 2021, the Minister of Health refused to reassess its decision that Janssen's esketamine hydrochloride product (SPRAVATO)...
Rubin Thomlinson LLP
Beaucoup d'entre vous connaissent le terme « stress traumatique secondaire » – une forme de stress qui peut survenir lorsqu'une personne entend les détails d'un traumatisme ...
DiliTrust Canada Inc.
In the complex world of pharmaceutical contracts, mistakes are costly. Every deal made and every rule imposed come with risks that can negatively impact not only financial outcomes...
Siskinds LLP
Suboxone, a drug used for opioid dependence, has been reported to cause severe dental issues.
Torkin Manes LLP
As regulated health professionals, Ontario pharmacists owe a primary duty to the public. However, pressures within the profession are threatening to shift focus...
Lerners LLP
A 2022 study, released by a research team at the Université de Sherbrooke, provided the first comprehensive empirical study on wellness in the Canadian legal profession.
Turnpenny Milne
With a rising number of employees raising allegations of workplace misconduct and pursuing wrongful dismissal claims, it is more important than ever for employers...
Rubin Thomlinson LLP
Many of you will be familiar with the term secondary traumatic stress – a form of stress that can occur when one person hears details of a trauma experienced by another person.
Gluckstein Lawyers
The key to success in a birth injury case is proving liability. Liability has two essential elements: a breach of the standard of care and causation. Where the allegation is that a newborn...
Borden Ladner Gervais LLP
On March 14, 2024, the Government of British Columbia introduced Bill 12: Public Health Accountability and Cost Recovery Act.
Goodwin Procter LLP
On March 18, 2024, Fresenius Kabi ("Fresenius") and Formycon announced a settlement agreement with Johnson & Johnson regarding FYB202, a proposed ustekinumab biosimilar to STELARA in Europe and Canada.
Smart & Biggar
On February 16, 2024, the Minister of Health tabled the 2022 Annual Report of the Patented Medicine Prices Review Board (PMPRB).
Gowling WLG
Following Health Canada's cost-recovery proposal for natural health products ("NHPs") in May 2023 (discussed here), and extensive feedback submitted...
Smart & Biggar
On February 29, 2024, the Minister of Health announced the introduction of Bill C-64, An Act respecting pharmacare (Pharmacare Act), which "proposes the foundational principles...
Smart & Biggar
On February 23, 2024, Health Canada announced that it will expand the information available on the Generic Submissions Under Review (GSUR) list to include the following...
Smart & Biggar
In this article, we provide a further update on developments regarding biosimilars in Canada (approvals, pending submissions, litigation, regulatory, and market access) since our March 2023 update.
Smart & Biggar
On March 7, 2024, Health Canada published a Memorandum of Understanding (MOU) with the Competition Bureau (together, Participants) to advance their mutual interests and develop a framework...
Osler, Hoskin & Harcourt LLP
On March 14, 2024, the province of British Columbia proposed broad multi-government class action legislation to claim costs arising from "health-related wrongs".
McCarthy Tétrault LLP
Health Canada has published its long anticipated notice regarding changes to the Generic Submissions Under Review (GSUR) List.
Aird & Berlis LLP
The Government of British Columbia has announced its intention to facilitate civil suits by provincial and federal governments seeking cost recovery, on an unprecedented scale...
Mondaq Webinars
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Comparative Guides
Curated Content
Alberta Court Upholds Express Employee Agreement On Random Drug And Alcohol Testing
Stikeman Elliott LLP
Stikeman Elliott LLP
The CNESST Requires That Medical Masks Be Worn Continuously Indoors In Workplaces
Stikeman Elliott LLP
Stikeman Elliott LLP
Popular Contributors
Goodwin Procter LLP
United States
Turnpenny Milne
Canada
Fasken (French)
Canada
Upcoming Events
MAY04
Yes, These Regulations Apply To You: California’s New Pre-Transaction Market Impact Review Processes
Panel California United States
MAY05
Mondaq Advice Centres
